L-type high voltage-gated calcium channels cause an increase in diazepam binding inhibitor mRNA expression after sustained exposure to ethanol in mouse cerebral cortical neurons

Molecular Brain Research

Volumn 113, Issue 1-2, 2003, Pages 52-56

  Mohri, Yutaka ^a   Katsura, Masashi ^a   Shuto, Keijiro ^a   Tsujimura, Atsushi ^b   Ishii, Ryoji ^a   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Calcium influx; Cerebral cortical neurons; Diazepam binding inhibitor; Ethanol; High voltage gated calcium channels

Indexed keywords

ALCOHOL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIAZEPAM BINDING INHIBITOR; MESSENGER RNA; NIFEDIPINE; OMEGA AGATOXIN IVA; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0038243787     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00089-5     Document Type: Article

References (24)

1. Alho H., Bovolin P., Slobodyansky E. Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain. Neurochem. Res. 15:1990;209-216.
2. Alho H., Harjuntausta T., Schultz R., Pelto-Huikko M., Bovolin P. Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Neuropharmacology. 30:1991;1381-1386.
3. Braun A.P., Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu. Rev. Physiol. 57:1995;417-445.
4. 2+/calmodulin-dependent protein kinase cascades in transcriptional regulation. J. Biol. Chem. 276:2001;2975-2978.
5. Faingold C.L., N'Gouemo F., Riaz A. Ethanol and neurotransmitter interactions - from molecular to integrative effects. Prog. Neurobiol. 55:1998;509-535.
6. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennett D.C., Costa E. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. USA. 80:1983;3531-3533.
7. Katsura M., Ohkuma S., Chen D.-Z., Kuriyama K. Ethanol-induced alteration in activities of cerebral phosphatidylinositol 4,5-biphosphate-specific and cytosolic phospholipase C in the brain: analysis using NG 108-15 cells and brains from ethanol-inhaled mice. Neurochem. Int. 24:1994;541-547.
8. Katsura M., Higo A., Tarumi C., tsujimura A., Takesue M., Mohri Y., Shuto K., Ohkuma S. Mechanism for increase in expression of cerebral diazepam binding inhibitor mRNA by nicotine: involvement of L-type voltage-dependent calcium channels. Mol. Brain Res. 80:2000;132-141.
9. Katsura M., Ohkuma S., Tsujimura A., Kuriyama K. Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice. J. Pharmacol. Exp. Ther. 273:1995;1529-1533.
10. Katsura M., Ohkuma S., Xu J., Tsujimura A., Kuriyama K. Ethanol stimulates diazepam binding inhibitor (DBI) mRNA expression in primary cultured neurons. Mol. Brain Res. 34:1995;355-359.
11. Katsura M., Ohkuma S., Xu J., Hibino Y., Tsujimura A., Kuriyama K. Continuous treatment with nicotine increases diazepam binding inhibitor (DBI) and its mRNA in the mouse brain. Mol. Brain Res. 55:1998;345-349.
12. Katsura M., Hara A., Higo A., Tarumi C., Hibino Y., Ohkuma S. Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain. J. Neurochem. 71:1998;2638-2641.
13. Kuriyama K., Ohkuma S. Alteration in the function of cerebral neurotransmitter receptors during establishment of alcohol dependence: Neurochemical aspects. Alcohol Alcohol. 25:1990;239-249.
14. Little H.J. The role of neuronal calcium channels in dependence on ethanol and other sedatives/hypnotics. Pharmacol. Ther. 50:1991;347-365.
15. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
16. O'Brien C.P. Drug addiction and drug abuse. Hardman J.G., Limbird L.E., Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th Edition:2001;621-642 McGraw-Hill, New York.
17. Ohkuma S., Tomono S., Tanaka Y., Kuriyama K., Mukainaka T. Development of taurine synthesizing system in cerebral cortical neurons in primary culture. Int. J. Dev. Neurosci. 4:1986;384-395.
18. Ohkuma S., Katsura M., Tsujimura A. Alterations in cerebral diazepam binding inhibitor expression in drug dependence. A possible biochemical alteration common to drug dependence. Life Sci. 68:2001;1215-1222.
19. 2+ influx through voltage-dependent calcium channels. J. Neurochem. 76:2001;341-350.
20. Shoyab M., Gentry L.E., Marqurdt H., Todaro G.J. Isolation and characterization of a putative endogenous benzodiazepine (endozepine) from bovine and human brain. J. Biol. Chem. 261:1986;11968-11973.
21. Slobogyansky E., Kurriger G., Kultas-Ilinsky K. Diazepam binding inhibitor processing in the Rhesus monkey brain: an immunohistochemical study. J. Chem. Neuroanat. 5:1992;169-180.
22. Tan C.Y.K., Weaver D.F. Molecular pathogenesis of alcohol withdrawal seizures: the modified lipid-protein interaction mechanism. Seisure. 6:1997;255-274.
23. Walter H.J., Messing R.O. Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem. Int. 35:1999;95-101.
24. Young J.K. Immunoreactivity for diazepam binding inhibitor in Gomori-positive astrocytes. Regul. Pept. 50:1994;159-165.